Cambridge, MA, United States of America

David A Weitz

This inventor holds 47 USPTO granted patents and 27 published patent applications, plus 9 CIPO patents and 6 EPO patents, primarily in Microfluidic Systems. Top assignees: Harvard College, Brandeis University, Medical Research Council. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David A Weitz. Retrieved from https://idiyas.com/inventor/david-a-weitz-g3z75r3m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 47 

% Patents Active = 93.6

 

 

Average Co-Inventor Count = 4.8

ph-index = 14

Forward Citations = 1,635(Granted Patents)


Company Filing History:


Years Active: 2011-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Microfluidics
Fluid Manipulation
Droplet Assays
Genetic Analysis
Copolymers
High-Throughput Systems
Epigenetic Sequencing
Single-Cell Analysis
Hydrogel Compositions
Compartmentalized Chemistry
Acoustic Waves
Nucleic Acid Barcoding
47 patents (USPTO):Explore Patents

Title: Innovations in Gene Expression Dynamics: The Contributions of David A. Weitz

Introduction: David A. Weitz, based in Cambridge, MA, is a prominent inventor with an impressive portfolio of 38 patents. His groundbreaking work focuses on methodologies that advance the understanding of gene expression dynamics in single cells, particularly within the neurogenic regions of the adult brain.

Latest Patents: Among his latest innovations are methods for determining spatial and temporal gene expression dynamics during adult neurogenesis. These techniques include Nuc-seq, Div-Seq, and Dronc-Seq, all of which enable unbiased analysis of complex tissues. Nuc-seq is a scalable single nucleus RNA-Seq method that sensitively identifies closely related cell types within the adult hippocampus. Div-seq innovatively combines Nuc-seq with EdU-mediated labeling to track transcriptional dynamics of newly formed neurons in neurogenic regions. Furthermore, Dronc-Seq employs a microfluidic device to co-encapsulate individual nuclei within reverse emulsion aqueous droplets, allowing for versatile applications in droplet-based libraries and systems.

Career Highlights: Throughout his career, David A. Weitz has served in various prestigious roles. He has been associated with the President and Fellows of Harvard College, contributing to advancements in scientific research and innovation. His endeavors embody a commitment to pushing the boundaries of our understanding of cellular dynamics.

Collaborations: Weitz has collaborated with notable individuals in the field, including Keunho Ahn and Darren Roy Link. These partnerships have facilitated significant advancements in genetic research and have helped in the development of the innovative techniques that are now widely recognized.

Conclusion: David A. Weitz's contributions to the fields of gene expression dynamics and neurogenesis exemplify the power of innovation in scientific research. His patents not only reflect his expertise but also pave the way for future breakthroughs in understanding complex biological systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…